<VariationArchive RecordType="classified" VariationID="973221" VariationName="NM_024757.5(EHMT1):c.2079dup (p.Glu694fs)" VariationType="Duplication" Accession="VCV000973221" Version="5" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-07-29" DateCreated="2020-07-25" MostRecentSubmission="2020-07-25">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="961615" VariationID="973221">
      <GeneList>
        <Gene Symbol="EHMT1" FullName="euchromatic histone lysine methyltransferase 1" GeneID="79813" HGNC_ID="HGNC:24650" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q34.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="137619005" stop="137836127" display_start="137619005" display_stop="137836127" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="140513443" stop="140730578" display_start="140513443" display_stop="140730578" Strand="+" />
          </Location>
          <OMIM>607001</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EHMT1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EHMT1">Little evidence for dosage pathogenicity</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_024757.5(EHMT1):c.2079dup (p.Glu694fs)</Name>
      <CanonicalSPDI>NC_000009.12:137777939:CCC:CCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9q34.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="137777939" stop="137777940" display_start="137777939" display_stop="137777940" variantLength="1" positionVCF="137777939" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="140672391" stop="140672392" display_start="140672391" display_stop="140672392" variantLength="1" positionVCF="140672391" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>E687fs</ProteinChange>
      <ProteinChange>E694fs</ProteinChange>
      <ProteinChange>E663fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.140672394dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.140672394dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.137777942dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.137777942dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011776.1" sequenceAccession="NG_011776" sequenceVersion="1" change="g.163951dup">
            <Expression>NG_011776.1:g.163951dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145527.2" sequenceAccession="NM_001145527" sequenceVersion="2" change="c.2079dup">
            <Expression>NM_001145527.2:c.2079dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001138999.1" sequenceAccession="NP_001138999" sequenceVersion="1" change="p.Glu694fs">
            <Expression>NP_001138999.1:p.Glu694fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354259.2" sequenceAccession="NM_001354259" sequenceVersion="2" change="c.1986dup">
            <Expression>NM_001354259.2:c.1986dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341188.1" sequenceAccession="NP_001341188" sequenceVersion="1" change="p.Glu663fs">
            <Expression>NP_001341188.1:p.Glu663fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354263.2" sequenceAccession="NM_001354263" sequenceVersion="2" change="c.2058dup">
            <Expression>NM_001354263.2:c.2058dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341192.1" sequenceAccession="NP_001341192" sequenceVersion="1" change="p.Glu687fs">
            <Expression>NP_001341192.1:p.Glu687fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024757.5" sequenceAccession="NM_024757" sequenceVersion="5" change="c.2079dup" MANESelect="true">
            <Expression>NM_024757.5:c.2079dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079033.4" sequenceAccession="NP_079033" sequenceVersion="4" change="p.Glu694fs">
            <Expression>NP_079033.4:p.Glu694fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1951085667" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024757.5(EHMT1):c.2079dup (p.Glu694fs) AND Kleefstra syndrome 1" Accession="RCV001249618" Version="5">
        <ClassifiedConditionList TraitSetID="948">
          <ClassifiedCondition DB="MedGen" ID="C0795833">Kleefstra syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-06-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-06-04" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-07-25" MostRecentSubmission="2020-07-25">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="948" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2521" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Kleefstra syndrome 1</ElementValue>
                <XRef ID="MONDO:0027407" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Kleefstra syndrome is characterized by intellectual disability, autistic-like features, childhood hypotonia, and distinctive facial features. The majority of individuals function in the moderate-to-severe spectrum of intellectual disability although a few individuals have mild delay and total IQ within low-normal range. While most have severe expressive speech delay with little speech development, general language development is usually at a higher level, making nonverbal communication possible. A complex pattern of other findings can also be observed; these include heart defects, renal/urologic defects, genital defects in males, severe respiratory infections, epilepsyÂ / febrile seizures, psychiatric disorders, and extreme apathy or catatonic-like features after puberty.</Attribute>
                <XRef ID="NBK47079" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20945554</ID>
                <ID Source="BookShelf">NBK47079</ID>
              </Citation>
              <XRef ID="261494" DB="Orphanet" />
              <XRef ID="C0795833" DB="MedGen" />
              <XRef ID="MONDO:0027407" DB="MONDO" />
              <XRef Type="MIM" ID="610253" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2806980" SubmissionDate="2020-05-21" DateLastUpdated="2020-07-25" DateCreated="2020-07-25">
        <ClinVarSubmissionID localKey="NCH:2563|OMIM:610253" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001423650" DateUpdated="2020-07-25" DateCreated="2020-07-25" Type="SCV" Version="1" SubmitterName="Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital" OrgID="196472" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-06-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>[ACMG/AMP: PVS1, PS2, PM2] This alteration is a null variant in a gene where LOF is a known mechanism of disease [PVS1], is de novo in origin as it was not detected in the submitted parental specimens (identity confirmed) [PS2], is absent from or rarely observed in large-scale population databases [PM2].</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EHMT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_024757.4:c.2079dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610253" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7483583</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2806980" TraitType="Disease" MappingType="XRef" MappingValue="610253" MappingRef="OMIM">
        <MedGen CUI="C0795833" Name="Kleefstra syndrome 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

